Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer: the PANTERA Trial (Prostate cAncer Novel ThERApy)
Sponsor: Institute of Cancer Research, United Kingdom
Listed as NCT02409212, this PHASE2 trial focuses on Prostate Cancer and remains completed. Sponsored by Institute of Cancer Research, United Kingdom, it has been updated 7 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Dec 2018 — Feb 2019 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Cancer Research, United Kingdom
- Queen Mary University of London
- Sheffield Hallam University
- Sheffield Teaching Hospitals NHS Foundation Trust
- University College London Hospitals
- University of Sheffield
For direct contact, visit the study record on ClinicalTrials.gov .